Vaccine-Associated Disease Enhancement (VADE): Considerations in Postvaccination COVID-19
Introduction. The COVID-19 pandemic has entered a new phase with the roll-out of several vaccines worldwide at an accelerated phase. The occurrence of a more severe presentation of COVID-19 after vaccination may affect policymakers’ decision-making and vaccine uptake by the public. Vaccine-associate...
Guardado en:
Autores principales: | Rahajeng N. Tunjungputri, Erpryta Nurdia Tetrasiwi, Merlinda Veronica, Jacub Pandelaki, Fera Ibrahim, Erni Juwita Nelwan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c64001b677624cf493415f7f3fb91584 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Laboratory monitoring of postvaccination measles immunity
por: A. A. Ereshchenko
Publicado: (2020) -
Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis
por: Andreas Rogalewski, et al.
Publicado: (2007) -
Sudden Infant Death Due to Postvaccinal Myocarditis: A Case Report
por: Babak Salahshour, et al.
Publicado: (2021) -
DURATION OF POSTVACCINAL IMMUNITY AGAINST HEPATITIS B IN HEALTH CARE WORKERS IN ST. PETERSBURG
por: Z. P. Kalinina, et al.
Publicado: (2015) -
Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
por: Gautam Sanyal, et al.
Publicado: (2021)